Seoulin Bioscience Co.,Ltd. (KOSDAQ: A038070)
Health Care · Biotechnology · KR
₩3,810.00
-6.39% today · -39.5% 1Y
Seoulin Bioscience Co.,Ltd. (KOSDAQ: A038070) operates in the Biotechnology industry within the Health Care sector. The company is valued at $25.81M.
Over the last twelve months the share price has lost 39.5%, trading between 3.60K and 7.76K.
Tweenvest scores Seoulin Bioscience Co.,Ltd. across four factors: quality 66/100, value 60/100, growth 0/100. Its strongest factor is quality.
A038070 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $25.81M
- Revenue (TTM)
- $53.70M
- P/E
- —
- EPS
- 6.75
- Dividend yield
- —
- Beta (5Y)
- 0.57
- 52-week high
- ₩7,760.09
- 52-week low
- ₩3,600.00
- Avg volume (3M)
- —
- Shares outstanding
- 9.03M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Isofol Medical AB (publ)OM: ISOFOL | $26.73M | Skr0.83 | +3.51% |
| Kim Forest Enterprise Co., Ltd.TWSE: 6645 | $26.71M | NT$14.35 | +6.30% |
| Atossa Therapeutics, Inc.NasdaqCM: ATOS | $25.95M | $2.60 | -4.41% |
| Noile-Immune Biotech Inc.TSE: 4893 | $25.84M | ¥94.00 | -7.84% |
| Genesystem Co., Ltd.KOSDAQ: A363250 | $25.76M | ₩4,145.00 | +1.97% |
| Kainos Medicine, Inc.KOSDAQ: A284620 | $25.58M | ₩— | — |
| D. Western Therapeutics Institute, Inc.TSE: 4576 | $25.15M | ¥69.00 | -1.43% |
| Immutep LimitedASX: IMM | $24.85M | AU$0.02 | +4.35% |
Figures last refreshed Oct 18, 2026.